Purchase Order N6311618P0404
- Not listed
- This is a $83,175 firm fixed price purchase order awarded by the U.S. Navy's Bureau of Medicine and Surgery (BUMED) to Biofire Defense LLC on March 31, 2020 for the delivery of COVID-19 coronavirus test kits. The contract has a performance period ending on September 30, 2020. Biofire Defense is a for-profit limited liability company that manufactures biological agent identification products, including diagnostic testing systems, and has previously held prime and subcontract awards to provide...
- This federal contract award was made by the Bureau of Medicine and Surgery, a Defense agency, to Biofire Defense LLC, a for-profit limited liability company and manufacturer of goods. The $48,748.00 firm fixed price purchase order is for the delivery of a Respiratory Panel 2.1 IVD with 30 tests. The contract has an ultimate completion date of March 11, 2025. Biofire Defense LLC is a provider of biological agent identification products, including the Biofire FilmArray and RAZOR Mk II systems,...
- This is a $90,878.59 firm fixed price delivery order awarded by the U.S. Navy's Bureau of Medicine and Surgery to Biofire Defense LLC, a for-profit limited liability company that manufactures biological agent identification products. The award is for the delivery of Film Array kits, including the GI Panel, Bio Threat E, and FAIV Kits, which support respiratory infection testing. The contract has no set-aside designation and was issued under the Multiple Award Schedule (MAS) contract vehicle....
- This federal contract award, with ID N6264519P0076, was made by the Bureau of Medicine and Surgery (BUMED), a Defense agency, to Biofire Defense LLC, a for-profit limited liability company. The $78,492.00 firm fixed-price purchase order is for the delivery of "GLOBAL FEVER PANELS (INCREMENT #1)" and has an ultimate completion date of February 5, 2020. Biofire Defense is a manufacturer of biological agent identification products, including the Biofire FilmArray and RAZOR Mk II...
- This federal contract awarded by the Department of the Navy Bureau of Medicine and Surgery to Biofire Defense LLC is for the provision of Biofire COVID-19 Panel Kits. The $100,980.25 firm fixed price contract was awarded on March 26, 2020 for completion by March 31, 2020. Biofire Defense LLC is a for-profit limited liability company that manufactures goods related to biological threat detection, infectious disease testing, and public health preparedness. The contract has no set-aside...
- This federal contract award to Biofire Defense LLC, a for-profit limited liability company, is for the provision of medical supplies. The contract, valued at $14,104.53, was awarded on a firm fixed-price basis by the Bureau of Administration, a civilian agency. The award does not have a set-aside designation. Biofire Defense has previously received other federal contract and grant awards, including a $6.2 million cooperative agreement from the Department of Defense's Washington Headquarters...
- This federal contract award was issued by the Bureau of Medicine and Surgery, a Defense agency, to Biofire Defense LLC, a for-profit limited liability company that manufactures biological agent identification products. The award is a $84,669.42 firm fixed-price delivery order for 22 FilmArray Respiratory Disease Panel Kits, which are used for infectious disease testing. The award is not designated as a set-aside contract. Biofire Defense LLC has previously received other prime federal contract...
- This is a firm fixed-price purchase order contract awarded by the Bureau of Medicine and Surgery, a Defense agency, to Biofire Defense LLC, a for-profit limited liability company. The contract is for the delivery of various kits and products related to biological agent identification, including assays and test kits for pathogens such as Yersinia pestis, Bacillus anthracis, and other agents. The total ceiling value of the contract is $149,706.00, and the ultimate completion date is May 3, 2017....
- This contract was awarded by the Department of the Navy Bureau of Medicine and Surgery to Biofire Defense LLC, a for-profit limited liability company that manufactures biological agent identification products. The $110,208.97 firm fixed price purchase order is for goods and services related to biodefense and infectious disease diagnostics, with a performance location in Washington, DC. No set-aside was used. Biofire Defense has previously received other federal contracts and grants, including...
- This federal contract award to Biofire Defense LLC is for the provision of medical supplies with a ceiling value of $25,000.00. The contract is a firm fixed price purchase order awarded by the Bureau of Administration, a civilian agency. Biofire Defense is a for-profit limited liability company that manufactures biological agent identification products, including diagnostic assays, test kits, and testing platforms. The company has previously received other federal contract and grant awards...
This federal contract award with a ceiling value of $97,415.75 was issued by the Bureau of Medicine and Surgery (BUMED), a Defense agency, to Biofire Defense LLC, a for-profit limited liability company. The contract is for the delivery of a FAIV KIT, RESPIRATORY PANEL, IVD 30 TEST and has a firm fixed price pricing type with a period of performance through September 28, 2018. There is no set-aside designation indicated for this award. In addition to this contract, Biofire Defense has received a range of past prime and subcontract awards from the Department of Defense, Department of State, National Institutes of Health, and Department of Health and Human Services for the provision of biological threat detection systems, infectious disease testing products and services, and COVID-19 response efforts. This includes a $6.2 million cooperative agreement from the Department of Defense's Washington Headquarters Service to expand manufacturing capacity for Department of Defense COVID test kits, as well as an indefinite delivery contract from the Army's Acquisition Support Center Chemical and Biological Defense organization valued at up to $18.8 million through January 2029 for sustainment of the Next Generation Diagnostic System.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Funding Only Action | ($444) | 4/21/20 | |
| Not listed | Not listed | $97.9k | 9/11/18 |